Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection

Lancet Infect Dis. 2024 May 3:S1473-3099(24)00258-5. doi: 10.1016/S1473-3099(24)00258-5. Online ahead of print.
No abstract available